Career history of Dennis Hom
Former positions of Dennis Hom
| Companies | Position | Start | End |
|---|---|---|---|
| SAGIMET BIOSCIENCES INC. | Director of Finance/CFO | 2017-09-30 | 2023-07-31 |
| ACHAOGEN | Director of Finance/CFO | 2012-12-31 | 2014-03-30 |
| Investor Relations Contact | 2012-12-31 | 2014-03-30 | |
| Public Communications Contact | 2012-12-31 | 2014-03-30 | |
| AMGEN INC. | Corporate Officer/Principal | 2010-12-31 | 2011-12-31 |
Training of Dennis Hom
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistics
International
| United States | 5 |
Operational
| Director of Finance/CFO | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| SAGIMET BIOSCIENCES INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Dennis Hom
- Experience
